scPharmaceuticals Inc.
SCPHDelisted Oct 7, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001604950
scPharmaceuticals Inc. was delisted on Oct 7, 2025; its insiders filed their last Form 4 on Oct 7, 2025; 110 institutions reported holding it in 13F filings for Q3 2025, worth $232.3M in total; no superinvestor held it.
13F holders, Q3 2021
Institutional positions in scPharmaceuticals Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- −7 vs. Q2 2021
- Shares held
- 16.2M
- +201.2K (+1.3%) vs. Q2 2021
- Total value
- $107.9M
- +$10.0M (+10.2%) vs. Q2 2021
- New holders
- 2
- 12 more added
- Sold out
- 9
- 11 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SCPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 110 | $232.3M |
| Q2 2025 | 98 | $145.7M |
| Q1 2025 | 88 | $98.7M |
| Q4 2024 | 86 | $140.8M |
| Q3 2024 | 95 | $169.8M |
| Q2 2024 | 77 | $121.0M |
| Q1 2024 | 76 | $134.2M |
| Q4 2023 | 81 | $175.4M |
| Q3 2023 | 73 | $213.1M |
| Q2 2023 | 81 | $290.8M |
| Q1 2023 | 63 | $223.2M |
| Q4 2022 | 59 | $153.5M |
| Q3 2022 | 40 | $91.3M |
| Q2 2022 | 38 | $75.9M |
| Q1 2022 | 37 | $90.1M |
| Q4 2021 | 33 | $80.0M |
| Q3 2021 | 31 | $107.9M |
| Q2 2021 | 38 | $97.9M |
| Q1 2021 | 46 | $114.1M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding scPharmaceuticals Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 60 | $0 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 106 | $705 | 0.00% | −153−59.1% | Reduced |
| Royal Bank of Canada | 79 | $1.00K | 0.00% | −795−91.0% | Reduced |
| Barclays PLC | 814 | $5.00K | 0.00% | +44+5.7% | Added |
| UBS Group AG | 843 | $6.00K | 0.00% | +139+19.7% | Added |
| Bank of America Corp | 1,154 | $8.00K | 0.00% | −339−22.7% | Reduced |
| Advisor Group Holdings, Inc. | 3,857 | $25.0K | 0.00% | +3,500+980.4% | Added |
| Envestnet Asset Management Inc | 10,696 | $71.0K | 0.00% | +10,696 | New |
| State Street Corp | 14,000 | $93.0K | 0.00% | +14,000 | New |
| HRT Financial LP | 16,189 | $107.0K | 0.00% | −4,072−20.1% | Reduced |
| Ergoteles LLC | 27,116 | $180.0K | 0.01% | −756−2.7% | Reduced |
| Millennium Management LLC | 33,542 | $223.0K | 0.00% | −24,175−41.9% | Reduced |
| Bank of New York Mellon Corp | 34,643 | $230.0K | 0.00% | 00.0% | Unchanged |
| Zacks Investment Management | 36,989 | $246.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 50,110 | $333.0K | 0.00% | +225+0.5% | Added |
| BlackRock Inc. | 58,105 | $387.0K | 0.00% | −4,092−6.6% | Reduced |
| Morgan Stanley | 70,093 | $465.0K | 0.00% | +8,929+14.6% | Added |
| Geode Capital Management, LLC | 71,223 | $473.0K | 0.00% | +4,748+7.1% | Added |
| Dimensional Fund Advisors LP | 79,265 | $527.0K | 0.00% | +34,438+76.8% | Added |
| Boothbay Fund Management, LLC | 86,635 | $576.0K | 0.02% | −38,192−30.6% | Reduced |
| Jacobs Levy Equity Management, Inc | 102,207 | $680.0K | 0.00% | −36,397−26.3% | Reduced |
| Bridgeway Capital Management, LLC | 132,200 | $879.0K | 0.02% | +30,000+29.4% | Added |
| Renaissance Technologies LLC | 193,586 | $1.29M | 0.00% | −22,900−10.6% | Reduced |
| Worth Venture Partners, LLC | 300,760 | $2.00M | 0.90% | +136,766+83.4% | Added |
| Vanguard Group Inc | 617,048 | $4.10M | 0.00% | +8,100+1.3% | Added |
| J. Goldman & Co LP | 792,421 | $5.27M | 0.47% | +71,544+9.9% | Added |
| Ikarian Capital, LLC | 901,362 | $5.99M | 1.37% | −193,662−17.7% | Reduced |
| AIGH Capital Management LLC | 1,234,121 | $8.21M | 2.43% | +591,967+92.2% | Added |
| Ra Capital Management, L.P. | 2,731,170 | $18.2M | 0.25% | 00.0% | Unchanged |
| 5AM Venture Management, LLC | 3,831,474 | $25.5M | 5.17% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 4,797,148 | $31.9M | 0.35% | 00.0% | Unchanged |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −194,238−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −115,264−100.0% | Sold out |
| DAFNA Capital Management LLC | 0 | $0 | 0.00% | −38,891−100.0% | Sold out |
| First Trust Advisors LP | 0 | $0 | 0.00% | −23,614−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −3,174−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −2,112−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −39−100.0% | Sold out |